Tg Therapeutics (TGTX) Treasury Shares (2012 - 2026)

Tg Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $200.2 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 3169.64% year-over-year to $200.2 million in Q1 2026; TTM through Mar 2026 was $200.2 million, a 3169.64% increase from a year earlier, with the FY2025 full-year figure at $100.2 million, up 1013.71% from the prior year.
• Treasury Shares climbed to $200.2 million in Q1 2026 per TGTX's latest filing, from $100.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $12.9 million in Q1 2025 and bottomed at $41309.0 in Q3 2022.
• The 5-year median for Treasury Shares is $9.6 million (2023), against an average of $7.6 million.
• Across the five-year window, Treasury Shares changed 0.0% in 2022 and surged 4562.63% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $234000.0 in 2022, then changed by 0.0% to $234000.0 in 2023, then soared by 3746.15% to $9.0 million in 2024, then surged by 1013.71% to $100.2 million in 2025, then soared by 99.73% to $200.2 million in 2026.
• Per Business Quant, the three latest TGTX Treasury Shares figures stand at $200.2 million (Q1 2026), $100.2 million (Q4 2025), and $100.2 million (Q3 2025).